Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

Todd Neale

October 02, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Daily News

HF Risks Stick Around Even When Ejection Fraction Improves

Todd Neale

August 01, 2025

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Daily News

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

Todd Neale

July 03, 2023

News Conference News ESC Heart Failure 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

L.A. McKeown

June 06, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Conference News ACC 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Michael O'Riordan

March 28, 2020

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

Advertisement

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

HF Risks Stick Around Even When Ejection Fraction Improves

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Acute HF Patients Live Longer When Seen by Specialists

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

Vast Majority of HFrEF Patients Eligible for Vericiguat

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Guideline-Directed Therapies Underused in Frail HF Patients

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content